Statistics

Total Visits

Views
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer60

Select a period of time:

Number of views in the range

Views
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer43

Views

Views
February 20251
March 202516
April 20252
May 20250
June 20250
July 202524
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
Brazil14
United States7
Spain1
Ethiopia1
Kenya1
Nicaragua1
Portugal1
South Africa1
 

Top cities views

Views
Rio de Janeiro2
Addis Ababa1
Avaré1
Chicago1
Council Bluffs1
Durban1
Foz do Iguaçu1
Gramado1
Guarulhos1
Jundiaí1